Tian-Xiu Liu

1PUBLICATIONS

1CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Nov 10, 2021

Cost-Effectiveness Analysis of Camrelizumab Immunotherapy versus Docetaxel or Irinotecan Chemotherapy as Second-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma.

Ying-Tao Lin, Ying Chen, Tian-Xiu Liu

Pageof 1

Frequent Collaborators

1 joint publications

Ying-Tao Lin

Frequent Collaborators

1 joint publications

Ying-Tao Lin